European Association of Nuclear Medicine: Prostate cancer patients who are resistant to hormone treatment used to have a poor prognosis. Until recently, the diagnostic and therapeutic possibilities had been limited, but now innovative developments in nuclear medicine imaging and therapy open up promising pathways. Novel substances used with PET/CT (positron-emission tomography combined with computed tomography) not only allow for better diagnosis but also offer treatment options where other therapies have failed.
Latest from John Shanahan
- Radiobiology and radiation hormesis (Charles Sanders) USofA
- Yellow jackets, unjustified taxation, fossil fuels (Paul Driessen) USofA France
- Decoding the United Nations agenda, lies, naivety, and ineptitude (Eric Jelinski) Canada
- Is Fighting Climate Change Really Fighting Pollution (Calvin Beisner, Cornwall Alliance) USofA
- Belief in socialism (Andrew Kenny, Free Market Foundation) South Africa